This CypA and KRAS G12V protein kit supports in vitro studies of Cyclophilin A driven complex formation with oncogenic KRAS G12V. Applications include molecular glue discovery, CypA-KRAS G12V ternary complex research, binding assay development, SPR, BLI, AlphaScreen, TR-FRET, pull-down workflows. Technical specifications are included below.- Quantity - Kit- Organism - Human- Purity - greater than 90%- Storage - -80 C - Biotinylated - Protein component dependent- Components - Recombinant Biotinylated Human KRAS G12V (1-185), 0.05 mg, featuring a specific G12V oncogenic mutation on the switch-sense domain of the isoform KRAS4B. Recombinant Biotinylated Human Wild-Type KRAS (1-185), 0.05 mg, included for critical counter-screening and selectivity profiling. Recombinant Human Cyclophilin A (CypA) (1-165), 0.1 mg, tagged with an N-terminal 6XHis tag for versatile assay orientation and capture. This product is for research use only.